Suppr超能文献

宿主-肿瘤关系。第三十四部分。恶性肿瘤患者血清中的透明质酸酶活性及透明质酸酶抑制剂

Host-tumor relationship. XXXIV. Hyaluronidase activity and hyaluronidase inhibitor in the serum of patients with malignant tumors.

作者信息

Koláŏvá M

出版信息

Neoplasma. 1977;24(3):285-90.

PMID:895938
Abstract

Current determinations of the hyaluronidase activity and hyaluronidase inhibitor in the serum of patients with a tumor disease failed to show a correlation between a lowered hyaluronidase activity and increased inhibitor level. The serum fraction that contained the inhibitor and which had been obtained by gel filtration of Sephadex G-200 had no in vitro inhibitory effect on the serum fraction containing hyaluronidase. Hence, the decreased serum hyaluronidase activity in these patients is not due to an increased levles of hyaluronidase inhibitor.

摘要

目前对肿瘤疾病患者血清中透明质酸酶活性和透明质酸酶抑制剂的测定未能显示出透明质酸酶活性降低与抑制剂水平升高之间的相关性。通过Sephadex G - 200凝胶过滤获得的含有抑制剂的血清组分对含有透明质酸酶的血清组分没有体外抑制作用。因此,这些患者血清透明质酸酶活性降低并非由于透明质酸酶抑制剂水平升高所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验